Translational research takes knowledge gained in the lab and applies it to create new therapies for patients. Craig B. Thompson writes that MSK will be able to continue to drive a revolution in our understanding of cancer and improve our ability to prevent, diagnose, and treat the disease.

Theranostics combines imaging and therapy for a search-and-destroy mission. Sam Frackowiak (pictured), Lisa Bodei, Heiko Schöder, Serge Lyashchenko, and others are advancing the field at MSK.

Doctors and scientists at MSK are desperately trying to figure out why more young patients like Rebecca, 33, are getting colorectal cancer — and how best to treat them.

After Owen Strong died of a glioblastoma at age 30, his girlfriend set off on a 1,100-mile bike ride to raise money for research, powering through her grief to make a difference for other families.

Fiona and Stanley Druckenmiller know the value of a good investment. That’s why they have their sights set on a new venture: supporting translational cancer research at MSK.

Immunologist Justin Perry was recently awarded a 2021 National Institutes of Health Director’s New Innovator Award for his research. He is also a 2021 Pew Biomedical Scholar.